RARE CIK: 1515673

Ultragenyx Pharmaceutical Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
335
FY22:
335
FY23:
–
FY24:
–
FY25:
564
(positive)
Change from FY21 to FY25
millions USD
FY21:
−382
FY22:
−649
FY23:
−569
FY24:
−536
FY25:
−535
(positive)
Change from FY21 to FY25
millions USD
FY21:
−368
FY22:
−621
FY23:
–
FY24:
–
FY25:
−474
(positive)
Change from FY21 to FY25
millions USD
FY21:
−453
FY22:
−702
FY23:
−609
FY24:
−567
FY25:
−571
(positive)
Change from FY21 to FY25
millions USD
FY21:
−454
FY22:
−707
FY23:
−607
FY24:
−569
FY25:
−575

All amounts in millions USD Data sources:SEC EDGARTwelve Data